Cited by 123Medication Adherence and ComplianceLipoproteins and Cardiovascular HealthHealthcare Policy and Management

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations

Pittman, Donald G., Chen, William, Bowlin, Steven J., Foody, JoAnne M.·2011·The American Journal of Cardiology

DOI 10.1016/j.amjcard.2011.01.052

Open this paper in CoChat — free account

Abstract

Statins are the primary agents used to decrease low-density lipoprotein cholesterol. Although adherence to statins improves the clinical outcomes, the affect of statin adherence on healthcare costs has not been well studied. To examine the relation among statin adherence, subsequent hospitalizations, and healthcare costs, we conducted a retrospective cohort study of 381,422 patients, aged 18 to 61 years, using an integrated pharmacy and medical claims database. We measured adherence using the medication possession ratio (MPR) for 12 months and the healthcare costs and cardiovascular disease-related hospitalizations during the subsequent 18 months. Of those studied, 258,013 (67.6%) were adherent (MPR ≥80%), 65,795 (17.3%) had an MPR of 60% to 79%, and 57,614 (15.1%) had an MPR of <60%. The adjusted all-cause total healthcare costs were lowest in the adherent group at $10,198 ± $39.4 (mean ± SE) versus $10,609 ± $77.7 (p <0.001) for an MPR of 60% to 79%, and $11,102 ± $84.3 (p <0.001) for an MPR of <60%. The adherent group had greater statin costs at $838 ± $1.0 versus $664 ± $2.0 (p <0.001) and $488 ± $2.2 (p <0.001). When evaluated by 5 levels of MPR, 0% to 59% and increments of 10% >60%, the adjusted total healthcare costs were lowest for the MPR 90% to 100% group and significantly greater statistically (p <0.001) for each lower level of adherence. Compared to the statin-adherent patients, cardiovascular disease-related hospitalizations were more likely for the patients with an MPR of 60% to 79% (odds ratio 1.12, 95% confidence interval 1.08 to 1.16) and an MPR of 0% to 59% (odds ratio 1.26, 95% confidence interval 1.21 to 1.31). In conclusion, statin adherence is associated with reductions in subsequent total healthcare costs and cardiovascular disease-related hospitalizations.

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2011.01.052

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Adherence to medication.
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,399
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
Rasmussen, J. N., Chong, A., & Alter, D. A. (2007) · JAMA · doi:10.1001/jama.297.2.177 · Cited by 975
Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 778
Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease
Ho, P. M., Magid, D. J., Shetterly, S. M., Olson, K. L., Maddox, T. M., Peterson, P. N., Masoudi, F. A., & Rumsfeld, J. S. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.12.011 · Cited by 587
Validation of Patient Reports, Automated Pharmacy Records, and Pill Counts With Electronic Monitoring of Adherence to Antihypertensive Therapy
Choo, P. W., Rand, C. S., Inui, T. S., Lee, M. T., Cain, E., Cordeiro-Breault, M., Canning, C. F., & Platt, R. G. (1999) · Medical Care · doi:10.1097/00005650-199909000-00002 · Cited by 546
Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect
Brookhart, M. A., Patrick, A. R., Dormuth, C. R., Avorn, J., Shrank, W. H., Cadarette, S. M., & Solomon, D. H. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm070 · Cited by 386

Show all 21 references

Sorted by citations

Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Adherence and health care costs
McGuire, M., & Iuga, A. O. (2014) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s19801 · Cited by 779
Influence of Patient Sex and Gender on Medication Use, Adherence, and Prescribing Alignment with Guidelines
Manteuffel, M., Williams, S., Chen, W., Verbrugge, R. R., Pittman, D. G., & Steinkellner, A. R. (2013) · Journal of Women s Health · doi:10.1089/jwh.2012.3972 · Cited by 423
Self-citation
The Impact of Medication Adherence on Coronary Artery Disease Costs and Outcomes: A Systematic Review
Bitton, A., Choudhry, N. K., Matlin, O. S., Swanton, K., & Shrank, W. H. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.09.004 · Cited by 256
Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education
Wei, M. Y., Ito, M. K., Cohen, J. D., Brinton, E. A., & Jacobson, T. A. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.03.001 · Cited by 260
Behavioral Hazard in Health Insurance *
Baicker, K., Mullainathan, S., & Schwartzstein, J. (2015) · The Quarterly Journal of Economics · doi:10.1093/qje/qjv029 · Cited by 247
Greater Adherence To Diabetes Drugs Is Linked To Less Hospital Use And Could Save Nearly $5 Billion Annually
Jha, A. K., Aubert, R. E., Yao, J., Teagarden, J. R., & Epstein, R. S. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1198 · Cited by 174
The Pennsylvania Project: Pharmacist Intervention Improved Medication Adherence And Reduced Health Care Costs
Pringle, J. L., Boyer, A., Conklin, M. H., McCullough, J. W., & Aldridge, A. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1398 · Cited by 134
A systematic review to assess adherence and persistence with statins
Deshpande, S., Quek, R. G. W., Forbes, C. A., de Kock, S., Kleijnen, J., Gandra, S. R., & Simpson, R. J. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1281109 · Cited by 90
Statin-Associated Muscle Disease: Advances in Diagnosis and Management
Taylor, B. A., & Thompson, P. D. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0670-z · Cited by 85
Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk
Fung, V., Graetz, I., Reed, M., & Jaffe, M. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191817 · Cited by 88
Assessment of Beliefs and Attitudes About Statins Posted on Twitter
Golder, S., O’Connor, K., Hennessy, S., Gross, R., & Gonzalez‐Hernandez, G. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8953 · Cited by 66
Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review
Claessen, B. E. P. M., Guedeney, P., Gibson, C. M., Angiolillo, D. J., Cao, D., Lepor, N. E., & Mehran, R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018897 · Cited by 67
Predictors of Statin Adherence
Mauskop, A., & Borden, W. B. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0221-2 · Cited by 61
Statins and Their Effect on PCSK9—Impact and Clinical Relevance
Taylor, B. A., & Thompson, P. D. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0604-3 · Cited by 65
Impact of Medication Adherence on Health Services Utilization in Medicaid
Roebuck, M. C., Kaestner, R. J., & Dougherty, J. S. (2018) · Medical Care · doi:10.1097/mlr.0000000000000870 · Cited by 58
Medication Adherence Is Associated with Having a Caregiver Among Cardiac Patients
Aggarwal, B., Liao, M., & Mosca, L. J. (2013) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9492-8 · Cited by 54
Expert opinion: the therapeutic challenges faced by statin intolerance
Patel, J., Martin, S. S., & Banach, M. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1197202 · Cited by 51
Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review
Kengne, A. P., Brière, J., Zhu, L., Li, J., Bhatia, M. K., Atanasov, P., & Khan, Z. M. (2023) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2023.2266135 · Cited by 55
Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial
Charland, S. L., Agatep, B. C., Herrera, V., Schrader, B. J., Frueh, F. W., Ryvkin, M., Shabbeer, J., Devlin, J. J., Superko, H. R., & Stanek, E. J. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.27 · Cited by 47
Systematic Review of the Effect of Adherence to Statin Treatment on Critical Cardiovascular Events and Mortality in Primary Prevention
Martin-Ruiz, E., Olry-de-Labry-Lima, A., Ocaña-Riola, R., & Epstein, D. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417745357 · Cited by 45
Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?
Ferrajolo, C., Arcoraci, V., Sullo, M. G., Rafaniello, C., Sportiello, L., Ferrara, R., Cannata, A., Pagliaro, C., Tari, M. G., Caputi, A. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102146 · Cited by 44
Effect of health information technology interventions on lipid management in clinical practice: A systematic review of randomized controlled trials
Aspry, K. E., Furman, R., Karalis, D. G., Jacobson, T. A., Zhang, A. M., Liptak, G. S., & Cohen, J. D. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.10.004 · Cited by 41
Cardiovascular Disease Risk–Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network
Saeed, A., Zhu, J., Thoma, F. W., Marroquin, O. C., Aiyer, A., Agarwala, A., Virani, S. S., Gulati, M., Lee, J. S., Reís, S. E., et al. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.007485 · Cited by 39
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994–2009, a registry study
Mundal, L. J., Veierød, M. B., Halvorsen, T., Holven, K. B., Ose, L., Iversen, P. O., Tell, G. S., Leren, T. P., & Retterstøl, K. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316666371 · Cited by 40
Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users
Sigglekow, F., Horsburgh, S., & Parkin, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242424 · Cited by 42
Evaluating the Impact of Prescription Fill Rates on Risk Stratification Model Performance
Chang, H., Richards, T. M., Shermock, K. M., Dalpoas, S. E., Kan, H. J., Alexander, G. C., Weiner, J. P., & Kharrazi, H. H. K. (2017) · Medical Care · doi:10.1097/mlr.0000000000000825 · Cited by 38
Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
Alwhaibi, M., Altoaimi, M., AlRuthia, Y. S., Meraya, A. M., Balkhi, B. S., Aldemerdash, A. M., Alkofide, H., Alhawassi, T. M., Alqasoumi, A. A., & Kamal, K. M. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s231873 · Cited by 37
Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
Li, J. H., Joy, S. V., Haga, S. B., Orlando, L. A., Kraus, W. E., Ginsburg, G. S., & Voora, D. (2014) · Journal of Personalized Medicine · doi:10.3390/jpm4020147 · Cited by 36
Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system
Cutler, R. L., Torres-Robles, A., Wiecek, E., Drake, B., van der Linden, N., Benrimoj, S. I., & García‐Cárdenas, V. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s191482 · Cited by 46
Factors influencing medication adherence in South Asian people with cardiac disorders: An ethnographic study
Ens, T., Seneviratne, C., Jones, C., & King‐Shier, K. M. (2014) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2014.02.015 · Cited by 33
A Review of Factors Influencing the Three Phases of Medication Adherence in People with Attention-Deficit/Hyperactivity Disorder
Khan, M. U., & Aslani, P. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0153 · Cited by 32
A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods
Davis, A. M., Taitel, M. S., Jiang, J., Qato, D. M., Peek, M. E., Chou, C.-H., & Huang, E. S. (2016) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-016-0247-7 · Cited by 31
Improving medication adherence in hypercholesterolemia: challenges and solutions
Gatwood, J. D., & Bailey, J. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s56056 · Cited by 29
South Asians’ cardiac medication adherence
Ens, T., Seneviratne, C., Jones, C., Green, T., & King‐Shier, K. M. (2013) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515113498187 · Cited by 28
Relation of Statin Nonadherence and Treatment Intensification
Pittman, D. G., Fenton, C. L., Chen, W. C., Haffner, S. M., & Pendergrass, M. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.07.008 · Cited by 26
Self-citation
Increasing Medicare Part D Enrollment In Medication Therapy Management Could Improve Health And Lower Costs
Stuart, B., Loh, F. E., Roberto, P. N., & Miller, L. M. (2013) · Health Affairs · doi:10.1377/hlthaff.2012.0848 · Cited by 25
The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease
Nastasi, D. R., Moxon, J. V., Norman, R., Trollope, A. F., Rowbotham, S. E., Quigley, F., Jenkins, J. S., & Golledge, J. (2020) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2020.08.129 · Cited by 25
Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) survey
Kherallah, R. Y., Rifai, M. A., Kamat, I., Krittanawong, C., Mahtta, D., Lee, M., Liu, J., Nasir, K., Elizondo, J. V., Patel, J., et al. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106715 · Cited by 24
Associations Between Statin Adherence Level, Health Care Costs, and Utilization
Zhao, Y., Zabriski, S., & Bertram, C. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.7.703 · Cited by 23
Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis
Armstrong-Hough, M. J., Sharma, S. K., Kishore, S. P., Akiteng, A. R., & Schwartz, J. I. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241555 · Cited by 23
Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations
Taylor, B. A. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0251-2 · Cited by 22
The importance of cholesterol medication adherence: the need for behavioral change intervention programs
Bosworth, H. B., Ngouyombo, B., Liška, J., Zullig, L. L., Atlani, C., & Beal, A. C. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s153766 · Cited by 22
Physicians' and other professionals' expectations and prognoses for mentally retarded individuals.
Wolraich, M. L., & Siperstein, G. N. (1986) · PubMed · Cited by 22
Racial differences in statin adherence following hospital discharge for ischemic stroke
Albright, K. C., Zhao, H., Blackburn, J. L., Limdi, N. A., Beasley, T. M., Howard, G., Bittner, V., Howard, V. J., & Muntner, P. (2017) · Neurology · doi:10.1212/wnl.0000000000003910 · Cited by 21
Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States
Baum, S. J., Rane, P., Nunna, S., Habib, M., Philip, K. J., Sun, K., Wang, X., & Wade, R. L. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100177 · Cited by 20
Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain
Taylor, B. A., Lorson, L., White, C. M., & Thompson, P. D. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.011 · Cited by 20
Vaccines Targeting PSCK9 for the Treatment of Hyperlipidemia
Tóth, Š., Pella, D., & Fedačko, J. (2020) · Cardiology and Therapy · doi:10.1007/s40119-020-00191-6 · Cited by 20
An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System
Lucas, J. E., Bazemore, T. C., Alo, C. J., Monahan, P. B., & Voora, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187809 · Cited by 19
Refill Rates of Accessories for Positive Airway Pressure Therapy as a Surrogate Measure of Long-Term Adherence
Patel, N. K., Sam, A., Valentin, A., Quan, S. F., & Parthasarathy, S. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.1772 · Cited by 19
Medication Adherence and Its Associated Factors Among Outpatients with Heart Failure
Jarab, A. S., Al-Qerem, W. A., Hamam, H., Alzoubi, K. H., Heshmeh, S. A., Mukattash, T. L., & Alefishat, E. A. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s410371 · Cited by 18
Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry
O'Brien, E. C., McCoy, L. A., Thomas, L. E., Peterson, E. D., & Wang, T. Y. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.04.011 · Cited by 18
Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model
Khatib, R., Patel, N., Laverty, U., McGawley, G., McLenachan, J., Shield, S., & Hall, A. S. (2018) · Open Heart · doi:10.1136/openhrt-2018-000921 · Cited by 18
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
Engebretsen, I., Munkhaugen, J., Bugge, C., Halvorsen, S., Ødegaard, K. M., Støvring, H., & Kristiansen, I. S. (2022) · European Heart Journal Open · doi:10.1093/ehjopen/oeac070 · Cited by 18
Statins and Nonadherence
Turin, A., Pandit, J. A., & Stone, N. J. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415578170 · Cited by 17
Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications
Axon, D. R., Vaffis, S., Chinthammit, C., Lott, B. E., Taylor, A. M., Pickering, M. K., Black, H. L., Warholak, T. L., & Campbell, P. J. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.12.1529 · Cited by 17
Pharmacy care and adherence to primary and secondary prevention cardiovascular medication: a systematic review of studies
Jalal, Z., Smith, F. J., Taylor, D. G., Patel, H., Finlay, K. A., & Antoniou, S. (2014) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2014-000455 · Cited by 17
Adherence to statins and development of atherosclerosis-related events. A systematic review and meta-analysis
Basios, A., Chatzi, C. A., Markozannes, G., Ntzani, E., Barkas, F., Tsilidis, K. K., Rizzo, M., Kalampoki, A., & Rizos, E. C. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109040 · Cited by 16
Incident User Cohorts for Assessing Medication Cost‐Offsets
Stuart, B., Loh, F. E., Roberto, P. N., & Miller, L. (2014) · Health Services Research · doi:10.1111/1475-6773.12170 · Cited by 15
Medication adherence and health beliefs among South Asian immigrants with diabetes in the United States: A qualitative study
Jamil, A., Jonkman, L. J., Miller, M. L., Jennings, L., & Connor, S. E. (2022) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1668 · Cited by 15
Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes
Raebel, M. A., Dyer, W., Nichols, G. A., Goodrich, G. K., & Schmittdiel, J. A. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1994 · Cited by 15
Low-Density Lipoprotein Cholesterol and Statin Usage Are Associated With Rates of Pseudarthrosis Following Single-Level Posterior Lumbar Interbody Fusion
Lavu, M. S., Eghrari, N. B., Makineni, P. S., Kaelber, D. C., Savage, J. W., & Pelle, D. W. (2023) · Spine · doi:10.1097/brs.0000000000004895 · Cited by 14
Association between statin use and physical performance in home-dwelling older patients receiving polypharmacy: cross-sectional study
Veddeng, S., Madland, H., Molden, E., Wyller, T. B., & Romskaug, R. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02942-7 · Cited by 14
Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany
Waßmuth, S., Rohe, K., NOACK, F., Noutsias, M., Treede, H., & Schlitt, A. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s197089 · Cited by 14
The importance of cholesterol follow-up testing under current statin treatment guidelines
Dansinger, M. L., Williams, P. T., Superko, H. R., & Schaefer, E. J. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.02.003 · Cited by 13
Adherence to statin therapy in patients with type 2 diabetes: An important dilemma.
(2015) · PubMed Central · Cited by 13
Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance
Zimolzak, A. J., Spettell, C. M., Fernandes, J. F., Fusaro, V. A., Palmer, N., Saria, S., Kohane, I. S., Jonikas, M. A., & Mandl, K. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079611 · Cited by 13
Does affirmative action reduce disparities in healthcare use by Indigenous peoples? Evidence from Australia's Indigenous Practice Incentives Program.
Saxby, K., Byrnes, J., de New, S. C., Nghiem, S., & Petrie, D. (2023) · Health Economics · doi:10.1002/hec.4645 · Cited by 11
Nitric oxide prevents atorvastatin‐induced skeletal muscle dysfunction and alterations in mice
D’Antona, G., Mascaro, A., Monopoli, A., Miglietta, D., Ongini, E., & Bottinelli, R. (2012) · Muscle & Nerve · doi:10.1002/mus.23465 · Cited by 12
Risk factors for lack of statin therapy in patients with diabetes and coronary artery disease
Zhang, H., Plutzky, J., Shubina, M., & Turchin, A. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.09.010 · Cited by 12
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice
Rottura, M., Scondotto, G., Barbieri, M. A., Sorbara, E. E., Nasso, C., Marino, S., Scoglio, R., Mandraffino, G., Pallio, G., Irrera, N., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.749686 · Cited by 11
Adherence to Daily, Weekly, and Monthly Dosing Regimens of Bisphosphonates for Osteoporosis Treatment in Postmenopausal Women in Japan: A Retrospective Study Using Claims Data
Kosaka, Y., Sugiyama, T., Hara, K., & Kobayashi, Y. (2021) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.255.147 · Cited by 11
Impact of positive airway pressure among obstructive sleep apnea patients.
Cai, Q., Tan, H., & Singer, J. R. (2012) · PubMed · Cited by 11
Clinical Characteristics of Patients With Statin Discontinuation in Korea: A Nationwide Population-Based Study
Kim, K., Hong, S., Han, K., & Park, C. (2024) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2024.13.1.41 · Cited by 11
Is there a role for warfarin anymore?
Jacobson, A. K. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.541.3798556 · Cited by 10
Prescriber and pharmacy variation in patient adherence to five medication classes measured using implementation during persistent episodes
Genberg, B. L., Rogers, W. H., Lee, Y., Qato, D. M., Dore, D. D., Hutchins, D. S., Brennan, T. A., Matlin, O. S., & Wilson, I. B. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4025 · Cited by 10
Factors influencing medication adherence and hypertension management revisited: recent insights from cancer survivors
Morgado, M., & Rolo, S. (2012) · Hypertension Research · doi:10.1038/hr.2012.100 · Cited by 10
Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction
Colantonio, L. D., Deng, L., Chen, L., Farkouh, M. E., Monda, K. L., Harrison, D. J., Maya, J. F., Kilgore, M. L., Muntner, P., & Rosenson, R. S. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6840-8 · Cited by 10
Statin persistence and adherence among older initiators: A nationwide cohort study using the national health insurance claims database in Japan
Tomida, J., Yoshida, T., Senda, S., Sato, T., Nakatsuma, A., & Iihara, N. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5622 · Cited by 12
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Guedeney, P., Claessen, B. E. P. M., Baber, U., Camaj, A., Sorrentino, S., Aquino, M. B., Blum, M., Chandiramani, R., Goel, R., Elsayed, S., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.03.005 · Cited by 9
A systematic review and meta-analysis on impact of suboptimal use of antidepressants, bisphosphonates, and statins on healthcare resource utilisation and healthcare cost
Park, K. H., Tickle, L., & Cutler, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269836 · Cited by 10
Using group-based trajectory modeling to characterize the association of past ACEIs/ARBs adherence with subsequent statin adherence patterns among new statin users
Majd, Z., Mohan, A., & Abughosh, S. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.07.007 · Cited by 10
Pharmacological Treatment of Diabetic and Non-Diabetic Patients With Coronary Artery Disease in the Real World of General Practice
Rottura, M., Molonia, A., Giorgi, D. A., Marino, S., Scoglio, R., Pallio, G., Irrera, N., Imbalzano, E., Altavilla, D., Squadrito, G., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.858385 · Cited by 7
Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States
Armstrong, S. O., & Little, R. A. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s213258 · Cited by 7
Association between medical complications according to continuity of care and medication adherence in patients with hypertension in Korea: a national population-based cohort study
Kim, D., & Cha, J. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073404 · Cited by 7
Prevalence and reasons for non-adherence to hyperlipidemia treatment
Kardas, P. (2013) · Open Medicine · doi:10.2478/s11536-013-0198-x · Cited by 7
The Contribution of Qualitative Research to Medication Adherence
McHorney, C. A. (2015) · Handbooks in health, work, and disability · doi:10.1007/978-1-4939-2920-7_28 · Cited by 7
Effect of nurse-led telephone follow-up to optimize adherence to preventive medication after screen-detected cardiovascular disease: a randomized controlled trial
Højgaard, H. G., Høgh, A. L., Lindholt, J. S., Frederiksen, K., & Dahl, M. (2025) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvaf047 · Cited by 6
Preventing cardiovascular disease in women
Lindquist, R. A., Witt, D., & Boucher, J. L. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328356db70 · Cited by 6
Simulated medication adherence: First and second-year pharmacy students' perceptions of adhering to a multi-drug medication regimen
Hamrick, J., Augustine, J. M., Pinkerton, D., Klein, C. M., & Elliott, J. (2020) · Currents in Pharmacy Teaching and Learning · doi:10.1016/j.cptl.2020.02.009 · Cited by 6
A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans
Chinthammit, C., Axon, D. R., Anderson, S., Lott, B. E., Taylor, A. M., Pickering, M. K., Black, H. L., Warholak, T. L., & Campbell, P. J. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.09.005 · Cited by 6
Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis
Yow, D. K. W., Ang, W. J., Yap, H. J., Ito, S., Liu, J., Ko, J., Tan, D. S.-Y., Lorenzatti, A., & Ang, C.-S. (2025) · eClinicalMedicine · doi:10.1016/j.eclinm.2025.103270 · Cited by 5
Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
Toth, P. P. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100186 · Cited by 5
Association between medication adherence and cardiovascular outcomes in patients with both diabetes and hypertension in primary care settings in Canada: A retrospective cohort study
Su, M., Qin, X. S., Li, Y., Upshur, R. E. G., Sullivan, F., Légaré, F., Greiver, M., Wu, S., & Wei, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319991 · Cited by 5
The Effect of Zero Copayments on Medication Adherence in a Community Pharmacy Setting
Jimenez, M., Alvarez, G., Wertheimer, A. I., Lai, L., Koh, L., Martinez, D., Hijazi, B. M., & Weinstein, M. D. (2019) · INNOVATIONS in pharmacy · doi:10.24926/iip.v10i2.1633 · Cited by 5
Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis
Kovacic, S., Habicht, S. D., & Eckert, G. P. (2025) · Journal of Nutritional Science · doi:10.1017/jns.2025.10043 · Cited by 4
“(57,60)”
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Bertolet, B. D., Cabral, K. P., Sullenberger, L. E., McAlister, J., Sandroni, T., & Patel, D. S. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00665-1 · Cited by 4
TEN-YEAR STATIN ADHERENCE IN SURVIVORS OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE AMI-QUEBEC STUDY
Huynh, T. T., Lecca, P., Montigny, M., Gagnon, R., Eisenberg, M. J., Lauzon, C., Mansour, S., Rinfret, S., Afilalo, M., Nguyen, M. T., et al. (2018) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.22374/1710-6222.25.2.5 · Cited by 5
A shared decision‐making intervention by pharmacy students to improve statin adherence
Osbaugh, N. A., & Billups, S. J. (2021) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1575 · Cited by 3
Medication adherence: the critical step towards better patient outcome
Desai, A. A., Mahajan, N., Sewlikar, S., & Pillai, R. (2014) · International Journal of Basic & Clinical Pharmacology · doi:10.5455/2319-2003.ijbcp20141006 · Cited by 3

Authors: Pittman, D. G., Chen, W., Bowlin, S. J., & Foody, J. M.
Affiliations: Brigham and Women's Hospital (US)
Corresponding author: Pittman, Donald G.
ORCID: Chen, William
Venue: The American Journal of Cardiology
Publisher: Elsevier BV
Published: 2011-06
Volume: 107
Issue: 11
Pages: 1662-1666
ISSN: 0002-9149 (ISSN-L)
DOI: 10.1016/j.amjcard.2011.01.052
OpenAlex: W2150048145
Cited by: 123
References: 21
Citations by year: 2026: 1 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 10 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 14 · 2012: 9
FWCI: 10.46
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The American Journal of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
Keywords: statin adherence, medication possession ratio, health care costs, cardiovascular hospitalization, cardiovascular disease, LDL cholesterol, medication adherence
MeSH terms: Adolescent, Adult, Female, Hospitalization, Humans, Male, Middle Aged, Retrospective Studies, Health Care Costs, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks